BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31880005)

  • 1. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas.
    Nöth U; Tichy J; Tritt S; Bähr O; Deichmann R; Hattingen E
    NMR Biomed; 2020 Mar; 33(3):e4242. PubMed ID: 31880005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.
    Müller A; Jurcoane A; Kebir S; Ditter P; Schrader F; Herrlinger U; Tzaridis T; Mädler B; Schild HH; Glas M; Hattingen E
    Cancer Med; 2017 Jan; 6(1):89-99. PubMed ID: 27891815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients.
    Hattingen E; Müller A; Jurcoane A; Mädler B; Ditter P; Schild H; Herrlinger U; Glas M; Kebir S
    Oncotarget; 2017 Aug; 8(32):53542-53551. PubMed ID: 28881830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.
    Lescher S; Jurcoane A; Veit A; Bähr O; Deichmann R; Hattingen E
    Neuroradiology; 2015 Jan; 57(1):11-20. PubMed ID: 25287076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region.
    Vallatos A; Al-Mubarak HFI; Birch JL; Galllagher L; Mullin JM; Gilmour L; Holmes WM; Chalmers AJ
    J Magn Reson Imaging; 2019 Aug; 50(2):529-540. PubMed ID: 30569620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MRI for analysis of peritumoral edema in malignant gliomas.
    Blystad I; Warntjes JBM; Smedby Ö; Lundberg P; Larsson EM; Tisell A
    PLoS One; 2017; 12(5):e0177135. PubMed ID: 28542553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.
    Kamimura K; Nakajo M; Yoneyama T; Fukukura Y; Hirano H; Goto Y; Sasaki M; Akamine Y; Keupp J; Yoshiura T
    Eur Radiol; 2019 Aug; 29(8):4133-4140. PubMed ID: 30488111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
    Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
    Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
    J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing Tumor Cell Infiltration and Vasogenic Edema in the Peritumoral Region of Glioblastoma at the Voxel Level via Conventional MRI Sequences.
    He L; Zhang H; Li T; Yang J; Zhou Y; Wang J; Saidaer T; Liu X; Wang L; Wang Y
    Acad Radiol; 2024 Mar; 31(3):1082-1090. PubMed ID: 37689557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Radiomics features of Peritumoral Vasogenic Edema extracted from fluid-attenuated inversion recovery images in glioblastoma and isolated brain metastasis, using T1-dynamic contrast-enhanced Perfusion analysis.
    Parvaze PS; Bhattacharjee R; Verma YK; Singh RK; Yadav V; Singh A; Khanna G; Ahlawat S; Trivedi R; Patir R; Vaishya S; Shah TJ; Gupta RK
    NMR Biomed; 2023 May; 36(5):e4884. PubMed ID: 36453877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain relaxometry after macrocyclic Gd-based contrast agent.
    Müller A; Jurcoane A; Mädler B; Ditter P; Schild H; Hattingen E
    Clin Neuroradiol; 2017 Dec; 27(4):459-468. PubMed ID: 28741075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of apparent diffusion coefficient in differentiation of glioblastoma from metastasis.
    Beig Zali S; Alinezhad F; Ranjkesh M; Daghighi MH; Poureisa M
    Neuroradiol J; 2021 Jun; 34(3):205-212. PubMed ID: 33417503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastomas with and without peritumoral fluid-attenuated inversion recovery (FLAIR) hyperintensity present morphological and microstructural differences on conventional MR images.
    Han Q; Lu Y; Wang D; Li X; Ruan Z; Mei N; Ji X; Geng D; Yin B
    Eur Radiol; 2023 Dec; 33(12):9139-9151. PubMed ID: 37495706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.
    Lin L; Xue Y; Duan Q; Sun B; Lin H; Huang X; Chen X
    Oncotarget; 2016 Oct; 7(42):69051-69059. PubMed ID: 27655705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
    Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
    J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of contrast agent dosage on longitudinal relaxation time, signal and apparent tumor volume in glioblastoma at 9.4T.
    Nickel A; Milford D; Fischer M; Bendszus M; Heiland S
    Z Med Phys; 2019 Aug; 29(3):206-215. PubMed ID: 30470504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging.
    Provenzale JM; McGraw P; Mhatre P; Guo AC; Delong D
    Radiology; 2004 Aug; 232(2):451-60. PubMed ID: 15215555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.
    Kamson DO; Juhász C; Buth A; Kupsky WJ; Barger GR; Chakraborty PK; Muzik O; Mittal S
    J Neurooncol; 2013 Mar; 112(1):121-32. PubMed ID: 23299463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of Primary Brain Tumors and Metastases with Fast Quantitative 3-Dimensional Magnetization Transfer.
    Garcia M; Gloor M; Bieri O; Radue EW; Lieb JM; Cordier D; Stippich C
    J Neuroimaging; 2015; 25(6):1007-14. PubMed ID: 25702714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.